Key result
A letter to the editor questioned the airway management strategy and the /kg dose of propofol used in a previously published case report of sugammadex in an anticipated difficult airway.
Answers are grounded in this paper and cite their sources.
This letter questions the airway management strategy and propofol dosing described in a previously published case report on anticipated difficult airways.
I read the case report by Paton et al. 1 and the accompanying editorial 2 with great interest and congratulate the authors for sharing their candid experience of this case. Can the authors confirm whether the previous (failed) awake fibreoptic intubation was attempted with the patient sitting upright, in order to optimise airway patency? Furthermore, given this previous failure, their planned expectation of needing to attempt fibreoptic intubation under general anaesthesia might have been predicted to be similarly unsuccessful. It could be argued therefore that awake tracheostomy would have been a more appropriate plan for this patient. At the end of the report, the authors mention that the use of propofol for hypnosis was ‘critical’ to their successful management, but in the body of the article they mention that propofol was given at 3 mg.kg−1 (a 200-mg bolus), which is an anaesthetic, rather than a hypnotic, dose. Could they clarify which was used?
No takes yet. Share an insight, caveat, or question.
S. W. Benham (2013) conducted a letter in Anticipated difficult airways. Sugammadex and propofol was evaluated. A letter to the editor questioned the airway management strategy and the /kg dose of propofol used in a previously published case report of sugammadex in an anticipated difficult airway.
Synapse has enriched 10 related papers. Consider them for comparative context: